VC  BlueStone Venture Partners

https://www.bluestonevp.com/





     Office Locations:

PO Box 17044
Tucson, AZ 85731

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded 2018, BlueStone Venture Partners is a life sciences venture capital fund capitalizing on the strength, creativity, and innovation found in entrepreneurial companies outside of the traditional investment hubs in the United States. BlueStone invests in early-stage startups that operate within the Life Sciences. The Fund primarily focuses on companies that reside within 'Core Four' verticals which are: Medical Devices, Diagnostics, Digital Health, and Life Science Research Tools. BlueStone's preference is for companies residing in the NATO States (New Mexico, Arizona, Texas, and Oklahoma), however, as a return-driven fund, BlueStone make investments in U.S. based companies regardless of geography if they fit certain metrics. The typical check size ranges from $250K to $1M.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrew More Director
    Chris Burwell Manager of Research
    Mara Aspinall Founder & Managing Director
    Tom Nickoloff Founder & Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/30/2024


      Rhombus


      CA


      $45,000,000


      Series C


     

    Portfolio companies include:


      Akadeum Life Sciences


      BroadSpot
        web link


      Elucid
        web link


      GT Medical Technologies
        web link


      Paradigm Diagnostics
        web link


      PreludeDx


      Pyx Health


      Rhombus
        web link


     

    Recent News: